Search - tctmd.com

Displaying 61 - 80 of 234

Sort: Relevancy | Date

AHA Issues Recommendations for Structuring Stroke Programs

News Conference News ISC 2023

AHA Issues Recommendations for Structuring Stroke Programs

February 16, 2023

Advent of Outpatient Endovascular Care Part of a ‘Sea Change’ in Medicine

News Conference News ISET 2023

Advent of Outpatient Endovascular Care Part of a ‘Sea Change’ in Medicine

January 26, 2023

‘Who’s In Charge of a Wound?’: Interventionalists Should Play a Role

News Conference News ISET 2023

‘Who’s In Charge of a Wound?’: Interventionalists Should Play a Role

January 18, 2023

Ralph Sacco, Neurologist and AHA Past President, Dies of Brain Cancer

News Daily News

Ralph Sacco, Neurologist and AHA Past President, Dies of Brain Cancer

January 17, 2023

As Outpatient Facilities Proliferate, So Too Does Scrutiny

News Conference News ISET 2023

As Outpatient Facilities Proliferate, So Too Does Scrutiny

January 17, 2023

For Vascular Labs, Accreditation Drives Quality and Objectivity

News Conference News ISET 2023

For Vascular Labs, Accreditation Drives Quality and Objectivity

January 17, 2023

TCTMD’s Top 10 Most Popular Stories for December 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2022

January 03, 2023

Top Endovascular News of 2022

News Daily News

Top Endovascular News of 2022

January 03, 2023

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

November 09, 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

November 07, 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

November 03, 2022

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

October 19, 2022

September 2022 News Roundup

News Opinion CV Team Dispatch

September 2022 News Roundup

September 01, 2022

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

News Daily News

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

August 15, 2022

TCTMD’s Top 10 Most Popular Stories for July 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2022

August 01, 2022

High Lp(a) May Predict Risk of CV and Limb Events in PAD

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

July 18, 2022

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

June 29, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.